Cancer Cell
Volume 10, Issue 6, December 2006, Pages 529-541
Journal home page for Cancer Cell

Article
Genomic and transcriptional aberrations linked to breast cancer pathophysiologies

https://doi.org/10.1016/j.ccr.2006.10.009Get rights and content
Under an Elsevier user license
open archive

Summary

This study explores the roles of genome copy number abnormalities (CNAs) in breast cancer pathophysiology by identifying associations between recurrent CNAs, gene expression, and clinical outcome in a set of aggressively treated early-stage breast tumors. It shows that the recurrent CNAs differ between tumor subtypes defined by expression pattern and that stratification of patients according to outcome can be improved by measuring both expression and copy number, especially high-level amplification. Sixty-six genes deregulated by the high-level amplifications are potential therapeutic targets. Nine of these (FGFR1, IKBKB, ERBB2, PROCC, ADAM9, FNTA, ACACA, PNMT, and NR1D1) are considered druggable. Low-level CNAs appear to contribute to cancer progression by altering RNA and cellular metabolism.

CELLCYCLE
HUMDISEASE

Cited by (0)

5

These authors contributed equally to this work.

6

These authors contributed equally to this work.